• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pH值、培养基和接种量的变化对不同喹诺酮类和氟喹诺酮类抗生素体外抗尿路病原体活性的影响。

Effects of changes in pH, medium and inoculum size on the in vitro activity of different quinolone and fluoroquinolone antibiotics against urinary pathogens.

作者信息

Gesu G P, Eftimiadi C, Debbia E, Schito G C

出版信息

Drugs Exp Clin Res. 1987;13(2):79-84.

PMID:3556122
Abstract

The antibacterial activity of quinolones and fluoroquinolones was evaluated against several strains of enterobacteria growing in Mueller-Hinton broth and in urine at different pH. The data obtained in alkaline urine and in Mueller-Hinton broth indicate that the MIC values of the fluoroquinolones are about 16-32 times inferior to those found in urine at pH 6. On the other hand, the activity of nalidixic acid and more particularly that of cinoxacin in urine appears to be optimum at this lower pH, showing MIC values only 2-4 times higher than those obtained in Mueller-Hinton media. Although the fluoroquinolones appear to have the highest degree of activity, a better MBC/MIC ratio was observed for cinoxacin and for nalidixic and oxolinic acids.

摘要

评估了喹诺酮类和氟喹诺酮类药物对在不同pH值的穆勒-欣顿肉汤和尿液中生长的几种肠杆菌菌株的抗菌活性。在碱性尿液和穆勒-欣顿肉汤中获得的数据表明,氟喹诺酮类药物的最低抑菌浓度(MIC)值比在pH值为6的尿液中发现的值低约16至32倍。另一方面,萘啶酸的活性,尤其是西诺沙星在尿液中的活性,在这个较低的pH值下似乎是最佳的,其MIC值仅比在穆勒-欣顿培养基中获得的值高2至4倍。尽管氟喹诺酮类药物似乎具有最高的活性程度,但西诺沙星、萘啶酸和恶喹酸的最低杀菌浓度(MBC)/最低抑菌浓度(MIC)比值更佳。

相似文献

1
Effects of changes in pH, medium and inoculum size on the in vitro activity of different quinolone and fluoroquinolone antibiotics against urinary pathogens.pH值、培养基和接种量的变化对不同喹诺酮类和氟喹诺酮类抗生素体外抗尿路病原体活性的影响。
Drugs Exp Clin Res. 1987;13(2):79-84.
2
In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates.新型6-氟喹诺酮类药物E-3604对临床分离株的体外抗菌活性
Drugs Exp Clin Res. 1987;13(3):133-6.
3
In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates.伊洛沙星(E-3432)对临床分离株的体外抗菌活性。
Drugs Exp Clin Res. 1987;13(2):75-7.
4
The post-antimicrobial suppressive effect of quinolone agents.
Drugs Exp Clin Res. 1987;13(2):63-7.
5
[Variations in vitro of the efficacy of quinolones as a function of pH].喹诺酮类药物疗效的体外变化与pH值的关系
Nephrologie. 1983;4(6):259-62.
6
In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.与西诺沙星、萘啶酸和吡哌酸相比,诺氟沙星在合成培养基和人尿中的体外活性。
Methods Find Exp Clin Pharmacol. 1983 Dec;5(10):731-4.
7
In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.诺氟沙星与萘啶酸、西诺沙星和恶喹酸的体外比较。
Arzneimittelforschung. 1983;33(12):1623-7.
8
Impact of pH on bacterial growth and activity of recent fluoroquinolones in pooled urine.pH 值对 pooled urine 中近期氟喹诺酮类药物的细菌生长和活性的影响。
Res Microbiol. 2011 Apr;162(3):249-52. doi: 10.1016/j.resmic.2011.01.004. Epub 2011 Feb 1.
9
In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).加雷沙星对全球收集的环丙沙星敏感和环丙沙星耐药肠杆菌科菌株(1999 - 2004年)的体外活性。
Diagn Microbiol Infect Dis. 2007 May;58(1):27-32. doi: 10.1016/j.diagmicrobio.2006.12.006. Epub 2007 Mar 23.
10
In vitro studies of tigemonam: a comparison of the minimum inhibitory and minimum bactericidal concentrations (MIC vs MBC).
J Chemother. 1989 May;1 Suppl 2:36-40.

引用本文的文献

1
Antimicrobial therapy for chronic bacterial prostatitis.慢性细菌性前列腺炎的抗菌治疗。
Cochrane Database Syst Rev. 2013 Aug 12;2013(8):CD009071. doi: 10.1002/14651858.CD009071.pub2.
2
Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.健康志愿者单次口服400毫克氟罗沙星与单次口服800毫克培氟沙星的尿排泄及杀菌活性比较
Antimicrob Agents Chemother. 1998 Jul;42(7):1659-65. doi: 10.1128/AAC.42.7.1659.
3
Sucralfate reduces the gastrointestinal absorption of norfloxacin.
硫糖铝会降低诺氟沙星的胃肠道吸收。
Antimicrob Agents Chemother. 1989 Jan;33(1):99-102. doi: 10.1128/AAC.33.1.99.
4
Inhibition of norfloxacin absorption by antacids.抗酸剂对诺氟沙星吸收的抑制作用。
Antimicrob Agents Chemother. 1990 Mar;34(3):432-5. doi: 10.1128/AAC.34.3.432.